🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06554678
Active, not recruiting

THRIVE Improves Early Postoperative Atelectasis in Long-Time Non-Tracheal Intubation Anesthesia for Gastrointestinal Endoscopy: a Clinical Study

NCT06554678 · tracked via the Priya Life Science China tracker
Sponsor
Northern Jiangsu People's Hospital
Phase
N/A
Started
2024-02-18
Last updated
2025-03-14

Condition(s) studied

Early Postoperative Atelectasis

Investigational drug(s) / intervention(s)

Transnasal humidified rapid insufflation ventilatory exchange(THRIVE)conventional oxygen mask

Transnasal humidified rapid insufflation ventilatory exchange(THRIVE): Transnasal humidified rapid insufflation ventilatory exchange(THRIVE)

conventional oxygen mask: conventional oxygen mask

Study summary

This study aims to explore the clinical effect of THRIVE in improving early postoperative atelectasis in patients undergoing long-term non-intubated anesthesia gastrointestinal endoscopy.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Multiple polyps resection, ESD(Endoscopic Submucosal Dissection) , EMR(Endoscopic Mucosal Resection), enteroscopy and other gastrointestinal endoscopic diagnosis and treatment were performed 2. The duration of anesthesia is more than 30 minutes, that is, from induction to withdrawal of anesthesia 3. ASA(American Society of Anesthesiologists) ≤ II 4.18kg/m2\<BMI\<30 kg/m2 5.Informed consent, voluntary participation in the experiment, and signed by the subject informed consent Exclusion Criteria: 1. ASA classification ≥ III; 2. History of previous lung or nasal surgery; 3. History of chronic obstructive pulmonary disease (COPD) or restrictive lung disease; 4. History of obstructive sleep apnea syndrome; 5. History of upper airway obstruction; 6. History of head and neck radiation therapy; 7. Significant nasal septum deviation; 8. Active infection (defined as a white blood cell count \>10\*10\^9 or a body temperature \>38°C); 9. Gastrointestinal perforation; 10. Combined use of other anesthetic methods or inhalation anesthetics outside of non-intubated intravenous anesthesia; 11. Concurrent other medical procedures besides the prescribed gastrointestinal endoscopic procedures, such as ERCP(Endoscopic Retrograde Cholangiopancreatography); 12. Severe communication disorders due to conditions like severe hearing impairment or dementia; 13. Disagreement with participation in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Northern Jiangsu People's Hospital Yangzhou Jiangsu
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06554678 on ClinicalTrials.gov ↗ ← All trials in China